Biotherapeutics Cell Line Development Market - Global Industry Analysis and Trends 2022

Albany, NY -- (SBWire) -- 01/05/2017 --Over the past few years, the demand for biotherapeutics has witnessed a significant rise, thanks to the increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cancer, and multiple sclerosis. This growth in the demand for biotherapeutics, together with the imminent launch of several biopharmaceutical drugs, has created a substantial demand for cell line development.

Download Exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8272

On the other hand, the strict rules and policies, regulating cell culture procedures in the production of biotherapeutics are creating difficulties for participants in their business expansion. However, unmet medical needs in emerging economies of Asia Pacific, Latin America, and Africa, is expected to provide lucrative opportunities for market players over the next few years.

The global market for is estimated to with the opportunity in biotherapeutics cell line development will rise from US$56 mn in 2014 to nearly US$100 mn by 2022, rising at a CAGR of 7.50% between 2015 and 2022.

Unmet Medical Needs in Emerging Economies to Present Lucrative Opportunities for Biotherapeutics Cell Line Development

The increasing prevalence of chronic diseases, stimulated by the rapid growth of the global geriatric population, has created favorable conditions for the progression of biotherapeutics. Currently, the increasing percentage of elderly individuals in the world's population is a significant trend, which is likely to intensify over the years to come. This rise in geriatric population is impelling the incidence of chronic, degenerative, and autoimmune diseases such as diabetes, cancer, and multiple sclerosis. Biotherapeutics, supported by its high efficiency, is grabbing substantial attention from patients as well as medical professionals for the treatment of these diseases, leading to a significant thrust to the development of biotherapeutics cell line across the world.

Looking forward, emerging economies in Asia Pacific, Latin America, and Africa, laden with unmet medical needs, will provide lucrative opportunities for biotherapeutics cell line development over the next few years. Apart from this, the growing demand for monoclonal antibodies is also projected to stimulate development activities for these cell lines in the near future.

Stringent Regulations Could Delay Product Development, Hamper Market Growth

Although the market for biotherapeutics cell line development looks thriving at present, the stringent norms and policies that regulate cell culture procedures in the production of biotherapeutics create severe issues for market participants.

As the development of stable cell line producing biologics needs to follow standard operating procedures and compliance, and requires to monitor product quality by performing tests in line with SOPs and regulations, existing players face delay in product development. These regulations also restrict the entry of new players in this market.

Read the Present Market Status of Biotherapeutics Cell Line Development at: http://www.transparencymarketresearch.com/biotherapeutics-cell-line-development-market.html

The top two players in the global biotherapeutics cell line development market are Becton Dickinson and Co. and Beckman Coulter. Boehringer Ingelheim Pharma GmbH & Co KG., CMC Biologics, Catalent Inc., Lonza Group Ltd., ProBioGen AG, Partec, SAFC, Sony Biotechnology Inc., Selexis SA, and Thermo Fisher Scientific Inc. are some of the other prominent market participants.

About TMR
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.